Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$1.14 - $1.87 $46,158 - $75,716
-40,490 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$1.34 - $3.53 $144 - $381
108 Added 0.27%
40,490 $72,000
Q4 2020

Feb 12, 2021

SELL
$0.87 - $1.26 $93 - $136
-108 Reduced 0.27%
40,382 $49,000
Q3 2020

Nov 04, 2020

BUY
$0.93 - $1.35 $369 - $535
397 Added 0.99%
40,490 $40,000
Q2 2020

Aug 12, 2020

BUY
$0.97 - $1.7 $4,360 - $7,641
4,495 Added 12.63%
40,093 $53,000
Q1 2020

May 04, 2020

SELL
$0.9 - $1.95 $1,225 - $2,655
-1,362 Reduced 3.69%
35,598 $39,000
Q4 2019

Feb 05, 2020

SELL
$1.0 - $1.49 $313 - $466
-313 Reduced 0.84%
36,960 $52,000
Q3 2019

Nov 08, 2019

SELL
$0.97 - $1.77 $251 - $458
-259 Reduced 0.69%
37,273 $44,000
Q2 2019

Aug 13, 2019

SELL
$0.96 - $1.89 $27,619 - $54,375
-28,770 Reduced 43.39%
37,532 $46,000
Q1 2019

May 06, 2019

SELL
$1.76 - $3.73 $3,780 - $8,012
-2,148 Reduced 3.14%
66,302 $117,000
Q4 2018

Feb 13, 2019

BUY
$2.01 - $4.21 $81,569 - $170,850
40,582 Added 145.62%
68,450 $253,000
Q3 2018

Nov 09, 2018

BUY
$2.18 - $3.44 $1,094 - $1,726
502 Added 1.83%
27,868 $77,000
Q2 2018

Aug 08, 2018

BUY
$2.05 - $4.09 $56,100 - $111,926
27,366 New
27,366 $86,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.